中文产业新闻精选评分79Chinese source
德达博妥单抗在华获批第二项乳腺癌适应症，覆盖不适合免疫治疗的mTNBC
Dato-DXd在华获批第二项乳腺癌适应症！我国不适合免疫治疗的mTNBC患者迎来一线治疗新选择
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
Dato-DXd在华获批第二项乳腺癌适应症！我国不适合免疫治疗的mTNBC患者迎来一线治疗新选择
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.